Ticker Details
NeoGenomics, Inc. NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida, Irvine, California and Nashville, and Tennessee.
IPO Date:	December 10, 2012
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$1.28B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 2.25%
Avg Daily Range (30 D):	$0.32 | 2.66%
Avg Daily Range (90 D):	$0.26 | 2.28%

Institutional Daily Volume
Avg Daily Volume:	.72M
Avg Daily Volume (30 D):	1.61M
Avg Daily Volume (90 D):	2.04M

Trade Size
Avg Trade Size (Sh.):	96
Avg Trade Size (Sh.) (30 D):	75
Avg Trade Size (Sh.) (90 D):	94

Institutional Trades
Total Institutional Trades:	3,873
Avg Institutional Trade:	$2.16M
Avg Institutional Trade (30 D):	$3.4M
Avg Institutional Trade (90 D):	$2.39M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.74M
Avg Closing Trade (30 D):	$4.64M
Avg Closing Trade (90 D):	$3.49M
Avg Closing Volume:	154.66K

News

Jun 25, 2025 @ 6:51 AM 3 Hot Trades for Insiders, But Are They Good Buys ... Source: Marketbeat.Com

May 6, 2025 @ 4:20 PM It's Not Too Late to Jump on These Under-the-Radar... Source: Marketbeat.Com

Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com

Feb 17, 2025 @ 10:28 PM Not Just a DEX: How Pineapple’s Mystery Mar... Source: N/A

Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS
Diluted EPS
Revenue	$727.33M	$190.17M	$727.33M
Gross Profit	$314.29M	$83.34M	$314.29M
Net Income / Loss	$-108.03M	$-9.88M	$-108.03M
Operating Income / Loss	$-115.88M	$-13.41M	$-115.88M
Cost of Revenue	$413.04M	$106.83M	$413.04M
Net Cash Flow	$-207.39M	$-4.53M	$-207.39M
PE Ratio

Splits
Apr 16, 2003	1:100
Nov 17, 2000	4:1